UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Lowe Wealth Advisors LLC

Lowe Wealth Advisors LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 24.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 134 shares of the healthcare conglomerate’s stock after buying an additional 26 shares during the period. Lowe Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $68,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. VitalStone Financial LLC raised its stake in shares of UnitedHealth Group by 600.0% during the second quarter. VitalStone Financial LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $36,000 after purchasing an additional 60 shares in the last quarter. Linscomb Wealth Inc. boosted its stake in UnitedHealth Group by 11.1% during the 2nd quarter. Linscomb Wealth Inc. now owns 1,054 shares of the healthcare conglomerate’s stock valued at $537,000 after purchasing an additional 105 shares in the last quarter. Qsemble Capital Management LP lifted its holdings in shares of UnitedHealth Group by 161.3% in the second quarter. Qsemble Capital Management LP now owns 8,414 shares of the healthcare conglomerate’s stock valued at $4,285,000 after buying an additional 5,194 shares during the period. Johnson Investment Counsel Inc. grew its holdings in UnitedHealth Group by 0.5% during the second quarter. Johnson Investment Counsel Inc. now owns 268,033 shares of the healthcare conglomerate’s stock worth $136,499,000 after acquiring an additional 1,363 shares during the period. Finally, BOKF NA boosted its holdings in UnitedHealth Group by 2.9% during the second quarter. BOKF NA now owns 66,217 shares of the healthcare conglomerate’s stock worth $33,722,000 after buying an additional 1,857 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $4.41 during midday trading on Friday, hitting $520.11. The company’s stock had a trading volume of 5,298,044 shares, compared to its average volume of 4,001,483. The stock’s 50 day simple moving average is $556.20 and its 200 day simple moving average is $561.20. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market capitalization of $478.65 billion, a price-to-earnings ratio of 33.88, a PEG ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.56 earnings per share. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.62%. UnitedHealth Group’s dividend payout ratio is 54.72%.

Analyst Ratings Changes

A number of brokerages recently issued reports on UNH. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday. KeyCorp initiated coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price on the stock. Piper Sandler lowered their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Barclays lifted their target price on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research note on Wednesday, November 27th. Two equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.